Literature DB >> 21119722

Trial watch: success for crizotinib in ALK-driven cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21119722     DOI： 10.1038/nrd3328

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Authors:  Eunice L Kwak; Yung-Jue Bang; D Ross Camidge; Alice T Shaw; Benjamin Solomon; Robert G Maki; Sai-Hong I Ou; Bruce J Dezube; Pasi A Jänne; Daniel B Costa; Marileila Varella-Garcia; Woo-Ho Kim; Thomas J Lynch; Panos Fidias; Hannah Stubbs; Jeffrey A Engelman; Lecia V Sequist; WeiWei Tan; Leena Gandhi; Mari Mino-Kenudson; Greg C Wei; S Martin Shreeve; Mark J Ratain; Jeffrey Settleman; James G Christensen; Daniel A Haber; Keith Wilner; Ravi Salgia; Geoffrey I Shapiro; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

2.  Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Authors:  James E Butrynski; David R D'Adamo; Jason L Hornick; Paola Dal Cin; Cristina R Antonescu; Suresh C Jhanwar; Marc Ladanyi; Marzia Capelletti; Scott J Rodig; Nikhil Ramaiya; Eunice L Kwak; Jeffrey W Clark; Keith D Wilner; James G Christensen; Pasi A Jänne; Robert G Maki; George D Demetri; Geoffrey I Shapiro
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

3.  EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

Authors:  Young Lim Choi; Manabu Soda; Yoshihiro Yamashita; Toshihide Ueno; Junpei Takashima; Takahiro Nakajima; Yasushi Yatabe; Kengo Takeuchi; Toru Hamada; Hidenori Haruta; Yuichi Ishikawa; Hideki Kimura; Tetsuya Mitsudomi; Yoshiro Tanio; Hiroyuki Mano
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245
  3 in total
  2 in total

1.  Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population.

Authors:  Lisandro F Lopes; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

2.  Molecular characterization of gallbladder cancer using somatic mutation profiling.

Authors:  Milind Javle; Asif Rashid; Chaitanya Churi; Siddhartha Kar; Mingxin Zuo; Agda Karina Eterovic; Graciela M Nogueras-Gonzalez; Filip Janku; Rachna T Shroff; Thomas A Aloia; Jean-Nicholas Vauthey; Steven Curley; Gordon Mills; Ivan Roa
Journal:  Hum Pathol       Date:  2013-11-12       Impact factor: 3.466
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.